In this book,
scholars with different disciplinary and national backgrounds argue for
possible answers and analyse case studies on current issues of governance in
biomedical research. These issues comprise among others the research-care
distinction, risk evaluation in early human trials, handling of incidental
findings, nocebo effects, cluster randomized trials, publication bias, or
consent in biobank research. This book demonstrates how new technologies and
research possibilities multiply or intensify already known governance
challenges, leaving room for ethical analysis and complex moral choices.
Clinical researchers, research ethics committee members and research ethicists
have all to deal with such challenges on a daily basis. While general
reflection on core concepts of research ethics is seldom pointless, those
confronted with hard moral choices do need more practical and contextualized
reflection on the said issues. This book particularly provides such
contextualized reflectionsand aims to inform all those who study, conduct,
regulate, fund, or participate in biomedical research.